维普中文期刊产品整合服务
33篇 您的检索式:作者名="Luca ME"
    题名 作者 年代 出处 被引量
1The second generation anti- cancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism显示文摘Alberto ME Lucas MF Pavelka M 2009J Phys Chem B2009,113,43:1
2Methylation-sensitive regulation of TMS1/ASC by the ETS factor,GA-binding protein-alpha显示文摘Lucas ME Crider KS Powell DR 2009J Biol Chem2009,284,14:1
3Increased prevalence of oxi -dant stress and inflammation in patients with moderate to se- vere chronic kidney disease显示文摘Oberg BP Mc ME Lucas FL 2004Kidney Int2004,65,3:1
4The second- generation anticancer drug nedaplatin: a theoretical investigation on the hydrolysis mechanism 显示文摘Alberto ME Lucas MF Pavelka M 2009J Plays Chem B2009,113,14:1
5Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis显示文摘Luca ME Kel JM van Rijs W 2005J Neuroimmunol2005,160,12:1
6Cardiac hypertrophy and arterial distensibility in essential hypertension 显示文摘Bouthier JD De Luca N Safar ME 1985Am Heart J1985,109,:1
7The second-generationanticancer drug Nedaplatin:a theoretical investigation on the hy-drolysis mechanism显示文摘Alberto ME Lucas MF Pavelka M 2009J Phys Chem B2009,113,14:1
8Functional characterization of the K257R and G319E-hGALE alleles found in patients with ostensibly peripheral epimerase deficiency galactosemia显示文摘Wakilenko J Lucas ME Thoden JB 2005Mol Genet Metab2005,84,1:1
9An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease显示文摘Background:With the rising global prevalence of fatty liver disease related to metabolic dysfunction,the association of this common liver condition with chronic kidney disease(CKD)has become increasingly evident.In 2020,the more inclusive term metabolic dysfunction-associated fatty liver disease(MAFLD)was proposed to replace the term non-alcoholic fatty liver disease(NAFLD).The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD.However,to date,there is no appropriate guidance on CKD in individuals with MAFLD.Furthermore,there has been little attention paid to the link between MAFLD and CKD in the Nephrology community.Methods and Results:Using a Delphi-based approach,a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD.Conclusions:This Delphi-based consensus statement provided guidance on the epidemiology,mechanisms,management and treatment of MAFLD and CKD,as well as the relationship between the severity of MAFLD and risk of CKD,which establish a framework for the early prevention and management of these two common and interconnected diseases.Dan-Qin Sun Giovanni Targher Christopher D.Byrne David C.Wheeler Vincent Wai-Sun Wong Jian-Gao Fan Herbert Tilg Wei-Jie Yuan Christoph Wanner Xin Gao Michelle T.Long Mehmet Kanbay Mindie H.Nguyen Sankar D.Navaneethan Yusuf Yilmaz Yuli Huang Rino A.Gani Pierluigi Marzuillo Jérôme Boursier Huijie Zhang Chan-Young Jung Jin Chai Luca Valenti George Papatheodoridis Giovanni Musso Yu-Jun Wong Mohamed El-Kassas Nahum Méndez-Sánchez Silvia Sookoian Michael Pavlides Ajay Duseja Adriaan G.Holleboom Junping Shi Wah-Kheong Chan Yasser Fouad Junwei Yang Sombat Treeprasertsuk Helena Cortez-Pinto Masahide Hamaguchi Manuel Romero-Gomez Mamun Al Mahtab Ponsiano Ocama Atsushi Nakajima Chunsun Dai Mohammed Eslam Lai Wei Jacob George Ming-Hua Zheng 2023Hepatobiliary Surgery and Nutrition2023,12,3:1
10Physical activity and exercise in asthma:relevance to etiology and treatment显示文摘LUCAS SR THOMAS A PLATTS ME 2005J Allergy Clin Immunol2005,115,:1
11Cardiac hypertrophy and arterial distensibility in essential hypertension显示文摘Bouthier JD De Luca N Safar ME 1985Am Heart1985,109,:1
12The second-generation anticancer drug Nedaplatin:a theoretical investigation on the hydrolysis mechanism显示文摘Alberto ME Lucas MF Pavelka M 2009J Phys Chem B2009,113,14:1
13The second-gen eration aticancer drug nedaplantin:a theoretical investigation on the by drolysis mechanism显示文摘Alberto ME Lucas MF Pavelka M 2009J Phys Chemo B2009,113,14:1
14The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism 显示文摘Alberto ME Lucas MF Pavelka M 2009J Phys Chem B2009,113,14:1
15Toughness, bonding and fluoride - release properties of hydroxyapatite - added glass ionomer cement 显示文摘Lucas ME Aftra K Nishino M 2003Biomaterials2003,24,21:1
16The effect of adding hydroxyapatite on the flexural strength of glass ionomer cement 显示文摘Arita K Lucas ME Nishino M 2003Dent Mater2003,22,2:1
17Functional characterization of the K257R and G319E-hGALE alleles found in patients with ostensibly peripheral epimerase deficiency galactosemia显示文摘Wasilenko J Lucas ME Thoden JB 2005Mol Genet Metab2005,84,1:1
18Gene expression analysis by cDNA-AFLP highlights a set of new signaling networks and translational control during seed dormancy breaking in Nicotiana plumbaginifolia显示文摘Jér?me Bove Philippe Lucas Béatrice Godin Laurent Ogé Marc Jullien Philippe Grappin 2005Plant Molecular Biology2005,,4:1
19The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells显示文摘 Davis ME Parthun MR 2004Leukemia2004,,:1
20The degradation pathways in chloride medium of the third generation anticancer drug oxaliplatin显示文摘Alberto ME Lucas MF Pavelka M 2008J Phys Chem B2008,112,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费